US20100189662A1 - DMS (derma membrane structure) in Foam Creams - Google Patents

DMS (derma membrane structure) in Foam Creams Download PDF

Info

Publication number: US20100189662A1
Authority: US; United States
Prior art keywords: emulsion; foam formulation; formulation according; foam; membrane
Prior art date: 2007-06-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

US12/664,732

Other languages

English (en)

Inventor

Thomas Neubourg

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Neubourg Skin Care GmbH and Co KG

Original Assignee

Neubourg Skin Care GmbH and Co KG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-19

Filing date

2008-06-19

Publication date

2010-07-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38830392&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20100189662(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-06-19 Application filed by Neubourg Skin Care GmbH and Co KG filed Critical Neubourg Skin Care GmbH and Co KG

2010-01-13 Assigned to NEUBOURG SKIN CARE GMBH & CO KG reassignment NEUBOURG SKIN CARE GMBH & CO KG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NEUBOURG, THOMAS

2010-07-29 Publication of US20100189662A1 publication Critical patent/US20100189662A1/en

2019-02-08 Priority to US16/270,929 priority Critical patent/US20190167539A1/en

2019-10-15 Priority to US16/601,733 priority patent/US20200289381A1/en

Status Abandoned legal-status Critical Current

Links

239000006260 foam Substances 0.000 title claims abstract description 111
239000012528 membrane Substances 0.000 title claims abstract description 38
239000006071 cream Substances 0.000 title claims description 12
239000000203 mixture Substances 0.000 claims abstract description 161
238000009472 formulation Methods 0.000 claims abstract description 115
239000000839 emulsion Substances 0.000 claims abstract description 94
239000000126 substance Substances 0.000 claims abstract description 62
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 44
239000003995 emulsifying agent Substances 0.000 claims description 61
239000003921 oil Substances 0.000 claims description 48
PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 29
150000002632 lipids Chemical class 0.000 claims description 28
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 27
150000003904 phospholipids Chemical class 0.000 claims description 25
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 24
WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 23
239000003380 propellant Substances 0.000 claims description 22
GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims description 21
-1 enzyme preparations Substances 0.000 claims description 21
238000000034 method Methods 0.000 claims description 21
239000013543 active substance Substances 0.000 claims description 19
239000007788 liquid Substances 0.000 claims description 16
239000002562 thickening agent Substances 0.000 claims description 16
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 15
UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 14
239000000787 lecithin Substances 0.000 claims description 13
235000010445 lecithin Nutrition 0.000 claims description 13
241000196324 Embryophyta Species 0.000 claims description 12
150000001875 compounds Chemical class 0.000 claims description 12
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 12
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 12
239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 claims description 11
ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 claims description 11
241001135917 Vitellaria paradoxa Species 0.000 claims description 11
235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 11
229940106189 ceramide Drugs 0.000 claims description 11
229940044176 ceramide 3 Drugs 0.000 claims description 11
239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 11
238000004519 manufacturing process Methods 0.000 claims description 11
229960002446 octanoic acid Drugs 0.000 claims description 11
150000001783 ceramides Chemical class 0.000 claims description 10
239000002537 cosmetic Substances 0.000 claims description 10
239000003795 chemical substances by application Substances 0.000 claims description 9
235000011187 glycerol Nutrition 0.000 claims description 9
229940067606 lecithin Drugs 0.000 claims description 9
229940057910 shea butter Drugs 0.000 claims description 8
239000000230 xanthan gum Substances 0.000 claims description 8
229920001285 xanthan gum Polymers 0.000 claims description 8
235000010493 xanthan gum Nutrition 0.000 claims description 8
229940082509 xanthan gum Drugs 0.000 claims description 8
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 7
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 6
239000003381 stabilizer Substances 0.000 claims description 6
229940043375 1,5-pentanediol Drugs 0.000 claims description 5
238000011049 filling Methods 0.000 claims description 5
WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 5
239000000243 solution Substances 0.000 claims description 5
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
240000001432 Calendula officinalis Species 0.000 claims description 4
SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 4
239000004164 Wax ester Substances 0.000 claims description 4
239000003814 drug Substances 0.000 claims description 4
239000003925 fat Substances 0.000 claims description 4
235000019197 fats Nutrition 0.000 claims description 4
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 4
229940101267 panthenol Drugs 0.000 claims description 4
235000020957 pantothenol Nutrition 0.000 claims description 4
239000011619 pantothenol Substances 0.000 claims description 4
150000003839 salts Chemical class 0.000 claims description 4
230000000475 sunscreen effect Effects 0.000 claims description 4
239000000516 sunscreening agent Substances 0.000 claims description 4
235000019386 wax ester Nutrition 0.000 claims description 4
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 3
239000004202 carbamide Substances 0.000 claims description 3
239000012459 cleaning agent Substances 0.000 claims description 3
150000002148 esters Chemical class 0.000 claims description 3
229920002674 hyaluronan Polymers 0.000 claims description 3
229960003160 hyaluronic acid Drugs 0.000 claims description 3
238000002156 mixing Methods 0.000 claims description 3
108090000623 proteins and genes Proteins 0.000 claims description 3
102000004169 proteins and genes Human genes 0.000 claims description 3
229940124597 therapeutic agent Drugs 0.000 claims description 3
GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 3
WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims description 2
RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims description 2
FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 2
AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 claims description 2
241001116389 Aloe Species 0.000 claims description 2
241000086254 Arnica montana Species 0.000 claims description 2
235000018185 Betula X alpestris Nutrition 0.000 claims description 2
235000018212 Betula X uliginosa Nutrition 0.000 claims description 2
235000003880 Calendula Nutrition 0.000 claims description 2
235000005881 Calendula officinalis Nutrition 0.000 claims description 2
235000009024 Ceanothus sanguineus Nutrition 0.000 claims description 2
102000008186 Collagen Human genes 0.000 claims description 2
108010035532 Collagen Proteins 0.000 claims description 2
241000195493 Cryptophyta Species 0.000 claims description 2
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 2
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
229940123907 Disease modifying antirheumatic drug Drugs 0.000 claims description 2
102000016942 Elastin Human genes 0.000 claims description 2
108010014258 Elastin Proteins 0.000 claims description 2
241000195955 Equisetum hyemale Species 0.000 claims description 2
241000208680 Hamamelis mollis Species 0.000 claims description 2
240000008669 Hedera helix Species 0.000 claims description 2
244000025221 Humulus lupulus Species 0.000 claims description 2
240000007049 Juglans regia Species 0.000 claims description 2
235000009496 Juglans regia Nutrition 0.000 claims description 2
244000208060 Lawsonia inermis Species 0.000 claims description 2
240000003553 Leptospermum scoparium Species 0.000 claims description 2
235000015459 Lycium barbarum Nutrition 0.000 claims description 2
244000246386 Mentha pulegium Species 0.000 claims description 2
235000016257 Mentha pulegium Nutrition 0.000 claims description 2
235000004357 Mentha x piperita Nutrition 0.000 claims description 2
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 2
208000001818 Pseudofolliculitis barbae Diseases 0.000 claims description 2
235000016976 Quercus macrolepis Nutrition 0.000 claims description 2
244000178231 Rosmarinus officinalis Species 0.000 claims description 2
241000605385 Ruscus Species 0.000 claims description 2
240000002299 Symphytum officinale Species 0.000 claims description 2
235000005865 Symphytum officinale Nutrition 0.000 claims description 2
244000269722 Thea sinensis Species 0.000 claims description 2
240000002657 Thymus vulgaris Species 0.000 claims description 2
235000007303 Thymus vulgaris Nutrition 0.000 claims description 2
235000009108 Urtica dioica Nutrition 0.000 claims description 2
241000700605 Viruses Species 0.000 claims description 2
FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 2
229930003268 Vitamin C Natural products 0.000 claims description 2
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 2
235000011399 aloe vera Nutrition 0.000 claims description 2
229940087168 alpha tocopherol Drugs 0.000 claims description 2
RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims description 2
230000000202 analgesic effect Effects 0.000 claims description 2
239000003242 anti bacterial agent Substances 0.000 claims description 2
230000003266 anti-allergic effect Effects 0.000 claims description 2
230000001741 anti-phlogistic effect Effects 0.000 claims description 2
230000002682 anti-psoriatic effect Effects 0.000 claims description 2
230000003356 anti-rheumatic effect Effects 0.000 claims description 2
239000000043 antiallergic agent Substances 0.000 claims description 2
229940088710 antibiotic agent Drugs 0.000 claims description 2
229940030999 antipsoriatics Drugs 0.000 claims description 2
239000003435 antirheumatic agent Substances 0.000 claims description 2
239000007864 aqueous solution Substances 0.000 claims description 2
229940036350 bisabolol Drugs 0.000 claims description 2
HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims description 2
FEOYLBRDNMCIHQ-UHFFFAOYSA-N carbonic acid;pyrrolidin-2-one Chemical compound OC(O)=O.O=C1CCCN1 FEOYLBRDNMCIHQ-UHFFFAOYSA-N 0.000 claims description 2
229920001436 collagen Polymers 0.000 claims description 2
239000000824 cytostatic agent Substances 0.000 claims description 2
230000001085 cytostatic effect Effects 0.000 claims description 2
229940079919 digestives enzyme preparation Drugs 0.000 claims description 2
229920002549 elastin Polymers 0.000 claims description 2
235000009569 green tea Nutrition 0.000 claims description 2
239000003102 growth factor Substances 0.000 claims description 2
239000005556 hormone Substances 0.000 claims description 2
229940088597 hormone Drugs 0.000 claims description 2
235000001050 hortel pimenta Nutrition 0.000 claims description 2
239000002917 insecticide Substances 0.000 claims description 2
239000004310 lactic acid Substances 0.000 claims description 2
235000014655 lactic acid Nutrition 0.000 claims description 2
229960005015 local anesthetics Drugs 0.000 claims description 2
239000000463 material Substances 0.000 claims description 2
229960003512 nicotinic acid Drugs 0.000 claims description 2
235000001968 nicotinic acid Nutrition 0.000 claims description 2
239000011664 nicotinic acid Substances 0.000 claims description 2
150000002823 nitrates Chemical class 0.000 claims description 2
150000002828 nitro derivatives Chemical class 0.000 claims description 2
239000000419 plant extract Substances 0.000 claims description 2
230000001737 promoting effect Effects 0.000 claims description 2
235000002020 sage Nutrition 0.000 claims description 2
239000000600 sorbitol Substances 0.000 claims description 2
230000003068 static effect Effects 0.000 claims description 2
239000001585 thymus vulgaris Substances 0.000 claims description 2
229960000984 tocofersolan Drugs 0.000 claims description 2
210000003462 vein Anatomy 0.000 claims description 2
235000019155 vitamin A Nutrition 0.000 claims description 2
239000011719 vitamin A Substances 0.000 claims description 2
235000019154 vitamin C Nutrition 0.000 claims description 2
239000011718 vitamin C Substances 0.000 claims description 2
229940045997 vitamin a Drugs 0.000 claims description 2
235000020234 walnut Nutrition 0.000 claims description 2
229940118846 witch hazel Drugs 0.000 claims description 2
230000029663 wound healing Effects 0.000 claims description 2
239000002076 α-tocopherol Substances 0.000 claims description 2
235000004835 α-tocopherol Nutrition 0.000 claims description 2
YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims 1
241001456088 Hesperocnide Species 0.000 claims 1
235000008694 Humulus lupulus Nutrition 0.000 claims 1
CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims 1
241000219492 Quercus Species 0.000 claims 1
ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims 1
230000001050 lubricating effect Effects 0.000 claims 1
VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims 1
150000008442 polyphenolic compounds Chemical class 0.000 claims 1
235000013824 polyphenols Nutrition 0.000 claims 1
239000012071 phase Substances 0.000 description 66
210000003491 skin Anatomy 0.000 description 58
235000019198 oils Nutrition 0.000 description 42
239000000194 fatty acid Substances 0.000 description 16
235000014113 dietary fatty acids Nutrition 0.000 description 15
229930195729 fatty acid Natural products 0.000 description 15
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 14
239000008346 aqueous phase Substances 0.000 description 13
239000012141 concentrate Substances 0.000 description 12
JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 12
229940032094 squalane Drugs 0.000 description 12
230000015572 biosynthetic process Effects 0.000 description 10
150000003626 triacylglycerols Chemical class 0.000 description 10
239000000693 micelle Substances 0.000 description 9
239000007787 solid Substances 0.000 description 9
230000007704 transition Effects 0.000 description 9
238000000265 homogenisation Methods 0.000 description 8
230000004888 barrier function Effects 0.000 description 7
235000012000 cholesterol Nutrition 0.000 description 7
150000004665 fatty acids Chemical class 0.000 description 7
238000002604 ultrasonography Methods 0.000 description 7
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
238000004140 cleaning Methods 0.000 description 6
125000005456 glyceride group Chemical group 0.000 description 6
229960003511 macrogol Drugs 0.000 description 6
238000002360 preparation method Methods 0.000 description 6
239000004094 surface-active agent Substances 0.000 description 6
239000002253 acid Substances 0.000 description 5
RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Chemical group CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
150000002191 fatty alcohols Chemical class 0.000 description 5
239000004615 ingredient Substances 0.000 description 5
230000007794 irritation Effects 0.000 description 5
230000010287 polarization Effects 0.000 description 5
239000000047 product Substances 0.000 description 5
230000008591 skin barrier function Effects 0.000 description 5
150000003408 sphingolipids Chemical class 0.000 description 5
YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 4
HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
244000027321 Lychnis chalcedonica Species 0.000 description 4
229930182558 Sterol Natural products 0.000 description 4
BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 4
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
239000002671 adjuvant Substances 0.000 description 4
150000005690 diesters Chemical class 0.000 description 4
239000006185 dispersion Substances 0.000 description 4
238000005187 foaming Methods 0.000 description 4
239000003205 fragrance Substances 0.000 description 4
150000002334 glycols Chemical class 0.000 description 4
229960003943 hypromellose Drugs 0.000 description 4
230000001681 protective effect Effects 0.000 description 4
229920006395 saturated elastomer Polymers 0.000 description 4
239000008347 soybean phospholipid Substances 0.000 description 4
229940031439 squalene Drugs 0.000 description 4
TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 4
235000003702 sterols Nutrition 0.000 description 4
150000003432 sterols Chemical class 0.000 description 4
238000003756 stirring Methods 0.000 description 4
JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 3
239000004166 Lanolin Substances 0.000 description 3
230000009471 action Effects 0.000 description 3
239000000443 aerosol Substances 0.000 description 3
150000001298 alcohols Chemical class 0.000 description 3
150000001720 carbohydrates Chemical class 0.000 description 3
235000014633 carbohydrates Nutrition 0.000 description 3
239000003086 colorant Substances 0.000 description 3
230000003247 decreasing effect Effects 0.000 description 3
SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 3
238000009775 high-speed stirring Methods 0.000 description 3
235000019388 lanolin Nutrition 0.000 description 3
229940039717 lanolin Drugs 0.000 description 3
229940127554 medical product Drugs 0.000 description 3
AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 3
239000008194 pharmaceutical composition Substances 0.000 description 3
230000037307 sensitive skin Effects 0.000 description 3
239000007921 spray Substances 0.000 description 3
230000000087 stabilizing effect Effects 0.000 description 3
239000001993 wax Substances 0.000 description 3
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
206010013786 Dry skin Diseases 0.000 description 2
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
244000025272 Persea americana Species 0.000 description 2
235000011236 Persea americana var americana Nutrition 0.000 description 2
ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
239000004904 UV filter Substances 0.000 description 2
230000004075 alteration Effects 0.000 description 2
239000003963 antioxidant agent Substances 0.000 description 2
235000006708 antioxidants Nutrition 0.000 description 2
229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 2
208000010668 atopic eczema Diseases 0.000 description 2
230000008901 benefit Effects 0.000 description 2
239000000969 carrier Substances 0.000 description 2
125000002091 cationic group Chemical group 0.000 description 2
229920003086 cellulose ether Polymers 0.000 description 2
239000008271 cosmetic emulsion Substances 0.000 description 2
230000037336 dry skin Effects 0.000 description 2
230000000694 effects Effects 0.000 description 2
230000007613 environmental effect Effects 0.000 description 2
239000000499 gel Substances 0.000 description 2
230000002209 hydrophobic effect Effects 0.000 description 2
230000006872 improvement Effects 0.000 description 2
230000010354 integration Effects 0.000 description 2
NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
238000005304 joining Methods 0.000 description 2
229920002521 macromolecule Polymers 0.000 description 2
238000000386 microscopy Methods 0.000 description 2
239000002480 mineral oil Substances 0.000 description 2
230000003020 moisturizing effect Effects 0.000 description 2
239000007764 o/w emulsion Substances 0.000 description 2
230000010355 oscillation Effects 0.000 description 2
239000002304 perfume Substances 0.000 description 2
230000008092 positive effect Effects 0.000 description 2
239000003755 preservative agent Substances 0.000 description 2
235000018102 proteins Nutrition 0.000 description 2
150000003856 quaternary ammonium compounds Chemical class 0.000 description 2
230000001235 sensitizing effect Effects 0.000 description 2
230000006641 stabilisation Effects 0.000 description 2
238000011105 stabilization Methods 0.000 description 2
210000000434 stratum corneum Anatomy 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
239000004408 titanium dioxide Substances 0.000 description 2
PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
IQXJCCZJOIKIAD-UHFFFAOYSA-N 1-(2-methoxyethoxy)hexadecane Chemical compound CCCCCCCCCCCCCCCCOCCOC IQXJCCZJOIKIAD-UHFFFAOYSA-N 0.000 description 1
QIZPVNNYFKFJAD-UHFFFAOYSA-N 1-chloro-2-prop-1-ynylbenzene Chemical compound CC#CC1=CC=CC=C1Cl QIZPVNNYFKFJAD-UHFFFAOYSA-N 0.000 description 1
RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
FUWVMBCPMRAWPG-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-hydroxyoctadecanoate Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)OCC(O)CO FUWVMBCPMRAWPG-UHFFFAOYSA-N 0.000 description 1
OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
AGNTUZCMJBTHOG-UHFFFAOYSA-N 3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]propane-1,2-diol Chemical compound OCC(O)COCC(O)COCC(O)CO AGNTUZCMJBTHOG-UHFFFAOYSA-N 0.000 description 1
208000002874 Acne Vulgaris Diseases 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
240000002470 Amphicarpaea bracteata Species 0.000 description 1
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
241000206575 Chondrus crispus Species 0.000 description 1
201000004624 Dermatitis Diseases 0.000 description 1
239000004375 Dextrin Substances 0.000 description 1
229920001353 Dextrin Polymers 0.000 description 1
239000004150 EU approved colour Substances 0.000 description 1
239000001856 Ethyl cellulose Substances 0.000 description 1
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
241000173371 Garcinia indica Species 0.000 description 1
239000001828 Gelatine Substances 0.000 description 1
241000206672 Gelidium Species 0.000 description 1
DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical compound CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 description 1
GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 1
235000019482 Palm oil Nutrition 0.000 description 1
235000019483 Peanut oil Nutrition 0.000 description 1
229920001363 Polidocanol Polymers 0.000 description 1
229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
239000004952 Polyamide Substances 0.000 description 1
239000004721 Polyphenylene oxide Substances 0.000 description 1
229920001214 Polysorbate 60 Polymers 0.000 description 1
108010009736 Protein Hydrolysates Proteins 0.000 description 1
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
244000305267 Quercus macrolepis Species 0.000 description 1
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
229920002125 Sokalan® Polymers 0.000 description 1
IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
244000274883 Urtica dioica Species 0.000 description 1
229930003427 Vitamin E Natural products 0.000 description 1
IJCWFDPJFXGQBN-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-octadecanoyloxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-RYNSOKOISA-N 0.000 description 1
FOLJTMYCYXSPFQ-CJKAUBRRSA-N [(2r,3s,4s,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-(octadecanoyloxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl octadecanoate Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)O[C@@H]1O[C@@]1(COC(=O)CCCCCCCCCCCCCCCCC)[C@@H](O)[C@H](O)[C@@H](CO)O1 FOLJTMYCYXSPFQ-CJKAUBRRSA-N 0.000 description 1
206010000496 acne Diseases 0.000 description 1
239000000654 additive Substances 0.000 description 1
235000010419 agar Nutrition 0.000 description 1
238000004220 aggregation Methods 0.000 description 1
230000002776 aggregation Effects 0.000 description 1
230000032683 aging Effects 0.000 description 1
230000000172 allergic effect Effects 0.000 description 1
230000007815 allergy Effects 0.000 description 1
CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
239000012874 anionic emulsifier Substances 0.000 description 1
125000000129 anionic group Chemical group 0.000 description 1
230000001857 anti-mycotic effect Effects 0.000 description 1
230000002141 anti-parasite Effects 0.000 description 1
230000002421 anti-septic effect Effects 0.000 description 1
239000002543 antimycotic Substances 0.000 description 1
239000003096 antiparasitic agent Substances 0.000 description 1
229940125687 antiparasitic agent Drugs 0.000 description 1
229940064004 antiseptic throat preparations Drugs 0.000 description 1
JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
239000001273 butane Substances 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
150000004649 carbonic acid derivatives Chemical class 0.000 description 1
150000007942 carboxylates Chemical class 0.000 description 1
239000005018 casein Substances 0.000 description 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
235000021240 caseins Nutrition 0.000 description 1
210000004027 cell Anatomy 0.000 description 1
229950009789 cetomacrogol 1000 Drugs 0.000 description 1
YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
229960001927 cetylpyridinium chloride Drugs 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000002734 clay mineral Substances 0.000 description 1
238000004581 coalescence Methods 0.000 description 1
229940071160 cocoate Drugs 0.000 description 1
239000000084 colloidal system Substances 0.000 description 1
239000013065 commercial product Substances 0.000 description 1
210000000736 corneocyte Anatomy 0.000 description 1
238000005336 cracking Methods 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
239000002781 deodorant agent Substances 0.000 description 1
239000000645 desinfectant Substances 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
235000019425 dextrin Nutrition 0.000 description 1
150000001983 dialkylethers Chemical class 0.000 description 1
POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 1
230000004064 dysfunction Effects 0.000 description 1
230000001804 emulsifying effect Effects 0.000 description 1
239000010696 ester oil Substances 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
235000019325 ethyl cellulose Nutrition 0.000 description 1
229920001249 ethyl cellulose Polymers 0.000 description 1
SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 1
239000000284 extract Substances 0.000 description 1
150000002194 fatty esters Chemical class 0.000 description 1
239000004872 foam stabilizing agent Substances 0.000 description 1
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
238000009499 grossing Methods 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
229940051250 hexylene glycol Drugs 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
239000001863 hydroxypropyl cellulose Substances 0.000 description 1
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
230000000544 hyperemic effect Effects 0.000 description 1
150000002484 inorganic compounds Chemical class 0.000 description 1
229910010272 inorganic material Inorganic materials 0.000 description 1
JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
230000002427 irreversible effect Effects 0.000 description 1
229940099367 lanolin alcohols Drugs 0.000 description 1
229950006462 lauromacrogol 400 Drugs 0.000 description 1
239000002502 liposome Substances 0.000 description 1
230000007774 longterm Effects 0.000 description 1
239000006210 lotion Substances 0.000 description 1
239000000155 melt Substances 0.000 description 1
244000005700 microbiome Species 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
229930014626 natural product Natural products 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
239000004006 olive oil Substances 0.000 description 1
235000008390 olive oil Nutrition 0.000 description 1
229940006093 opthalmologic coloring agent diagnostic Drugs 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
239000002540 palm oil Substances 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
239000002245 particle Substances 0.000 description 1
239000000312 peanut oil Substances 0.000 description 1
125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
230000035699 permeability Effects 0.000 description 1
239000008251 pharmaceutical emulsion Substances 0.000 description 1
108010022216 physiogel Proteins 0.000 description 1
229940068065 phytosterols Drugs 0.000 description 1
239000000049 pigment Substances 0.000 description 1
239000004584 polyacrylic acid Substances 0.000 description 1
229920002647 polyamide Polymers 0.000 description 1
229920000570 polyether Polymers 0.000 description 1
229920000223 polyglycerol Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
125000004402 polyphenol group Chemical group 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
159000000001 potassium salts Chemical class 0.000 description 1
239000002243 precursor Substances 0.000 description 1
239000001294 propane Substances 0.000 description 1
239000003531 protein hydrolysate Substances 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000001172 regenerating effect Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
239000005871 repellent Substances 0.000 description 1
230000002940 repellent Effects 0.000 description 1
229910052710 silicon Inorganic materials 0.000 description 1
239000010703 silicon Substances 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
235000012239 silicon dioxide Nutrition 0.000 description 1
239000000344 soap Substances 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
239000002904 solvent Substances 0.000 description 1
229940100515 sorbitan Drugs 0.000 description 1
239000001570 sorbitan monopalmitate Substances 0.000 description 1
235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
229940031953 sorbitan monopalmitate Drugs 0.000 description 1
239000001587 sorbitan monostearate Substances 0.000 description 1
235000011076 sorbitan monostearate Nutrition 0.000 description 1
229940035048 sorbitan monostearate Drugs 0.000 description 1
239000001589 sorbitan tristearate Substances 0.000 description 1
235000011078 sorbitan tristearate Nutrition 0.000 description 1
229960004129 sorbitan tristearate Drugs 0.000 description 1
238000005507 spraying Methods 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000008107 starch Substances 0.000 description 1
238000005728 strengthening Methods 0.000 description 1
229940035023 sucrose monostearate Drugs 0.000 description 1
150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
210000004243 sweat Anatomy 0.000 description 1
XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 1
229910001887 tin oxide Inorganic materials 0.000 description 1
AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
230000009466 transformation Effects 0.000 description 1
LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
229920002554 vinyl polymer Polymers 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
235000019165 vitamin E Nutrition 0.000 description 1
229940046009 vitamin E Drugs 0.000 description 1
239000011709 vitamin E Substances 0.000 description 1
239000007762 w/o emulsion Substances 0.000 description 1
238000005406 washing Methods 0.000 description 1

Images

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0295—Liquid crystals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
- A61K2800/33—Free of surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/82—Preparation or application process involves sonication or ultrasonication

Definitions

further conventional adjuvants such as fragrances, colorants, comedogene lipids (e.g. mineral oils) and physiologic emulsifiers are preferably omitted, since these components are potentially sensitizing and may lead to irritations of the skin.
a further preferred thickening agent is xanthan gum, especially Keltrol® CG xanthan gum.
inventive emulsions are prepared by means of a method comprising the following steps:

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Birds (AREA)
Chemical & Material Sciences (AREA)
Dermatology (AREA)
Emergency Medicine (AREA)
Dispersion Chemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Crystallography & Structural Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Cosmetics (AREA)
Medicinal Preparation (AREA)
Grain Derivatives (AREA)
Edible Oils And Fats (AREA)
Colloid Chemistry (AREA)

US12/664,732 2007-06-19 2008-06-19 DMS (derma membrane structure) in Foam Creams Abandoned US20100189662A1 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
US16/270,929 US20190167539A1 (en)	2007-06-19	2019-02-08	DMS (derma membrane structure) in Foam Creams
US16/601,733 US20200289381A1 (en)	2007-06-19	2019-10-15	DMS (derma membrane structure) in Foam Creams

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP07110571A EP2020221B1 (de)	2007-06-19	2007-06-19	DMS (Derma Membrane Structure) in Schaum-Cremes
EP071105571.2		2007-06-19
PCT/EP2008/057791 WO2008155389A2 (de)	2007-06-19	2008-06-19	Dms (derma membrane structure) in schaum-cremes

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
PCT/EP2008/057791 A-371-Of-International WO2008155389A2 (de)	2007-06-19	2008-06-19	Dms (derma membrane structure) in schaum-cremes

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
US16/270,929 Continuation US20190167539A1 (en)	2007-06-19	2019-02-08	DMS (derma membrane structure) in Foam Creams

Publications (1)

Publication Number	Publication Date
US20100189662A1 true US20100189662A1 (en)	2010-07-29

Family

ID=38830392

Family Applications (5)

Application Number	Title	Priority Date	Filing Date
US12/664,732 Abandoned US20100189662A1 (en)	2007-06-19	2008-06-19	DMS (derma membrane structure) in Foam Creams
US16/270,929 Abandoned US20190167539A1 (en)	2007-06-19	2019-02-08	DMS (derma membrane structure) in Foam Creams
US16/601,733 Abandoned US20200289381A1 (en)	2007-06-19	2019-10-15	DMS (derma membrane structure) in Foam Creams
US17/235,152 Abandoned US20220110842A1 (en)	2007-06-19	2021-04-20	DMS (derma membrane structure) in Foam Creams
US18/610,728 Pending US20240374485A1 (en)	2007-06-19	2024-03-20	DMS (derma membrane structure) in Foam Creams

Family Applications After (4)

Application Number	Title	Priority Date	Filing Date
US16/270,929 Abandoned US20190167539A1 (en)	2007-06-19	2019-02-08	DMS (derma membrane structure) in Foam Creams
US16/601,733 Abandoned US20200289381A1 (en)	2007-06-19	2019-10-15	DMS (derma membrane structure) in Foam Creams
US17/235,152 Abandoned US20220110842A1 (en)	2007-06-19	2021-04-20	DMS (derma membrane structure) in Foam Creams
US18/610,728 Pending US20240374485A1 (en)	2007-06-19	2024-03-20	DMS (derma membrane structure) in Foam Creams

Country Status (21)

Country	Link
US (5)	US20100189662A1 (de)
EP (3)	EP2020221B1 (de)
JP (2)	JP5971891B2 (de)
KR (6)	KR20230037060A (de)
CN (1)	CN101686903B (de)
AT (1)	ATE547088T1 (de)
AU (1)	AU2008265154B2 (de)
CA (1)	CA2691393C (de)
DK (1)	DK2020221T3 (de)
EA (1)	EA021149B1 (de)
ES (1)	ES2382890T3 (de)
HK (1)	HK1206588A1 (de)
HR (1)	HRP20120423T1 (de)
IL (1)	IL202088A0 (de)
MX (1)	MX2009013348A (de)
PL (1)	PL2020221T3 (de)
PT (1)	PT2020221E (de)
RS (1)	RS52337B (de)
UA (1)	UA98499C2 (de)
WO (1)	WO2008155389A2 (de)
ZA (1)	ZA200907797B (de)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20110308985A1 (en) *	2009-02-26	2011-12-22	Gina Van Bogaert	Composition of a liposomal gel containing hydrocortisone, its metabolites, precursors or mixtures thereof and the use thereof
US20120315315A1 (en) *	2010-03-02	2012-12-13	Neubourg Skin Care Gmbh & Co., Kg	Foam Formulations Containing at Least One Triterpenoid
US20150359723A1 (en) *	2013-02-19	2015-12-17	Neopharm Co., Ltd.	Composition externally used for subacid skin and cosmetic material including same
WO2016044374A1 (en) *	2014-09-18	2016-03-24	Glaxosmithkline Consumer Healthcare Holdings (Us) Llc	Novel formulations
US9468590B2 (en)	2009-12-10	2016-10-18	Neubourg Skin Care Gmbh & Co. Kg	Emulsifier-free, polymer-stabilized foam formulations
US9693956B2 (en)	2009-07-24	2017-07-04	Mika Pharma Gmbh	Liquid compositions capable of foaming and including active agents, and methods for making or developing same
US9884005B2 (en)	2011-06-23	2018-02-06	Cosmetic Warriors Limited	Aerated solid cosmetic composition
EP3338759A1 (de) *	2016-11-22	2018-06-27	CMS Lab Inc.	Vesikel, die saccharidisomerate, hydrolysierte lupineproteine und interkorneozytäre lipid-mimetika als wirkstoff enthalten, und zusammensetzung damit zur äusseren anwendung auf der haut
US10111826B2 (en)	2012-12-11	2018-10-30	Cosmetic Warriors Limited	Solid cosmetic composition having dispersed therein gas bubbles, and a process for making a solid cosmetic composition
WO2019194780A3 (en) *	2017-12-27	2020-01-02	Montero Gida Sanayi Ve Ticaret Anonim Sirketi	Sensitive care and cleansing compositions
IT201900004877A1 (it) *	2019-04-01	2020-10-01	Res Pharma Ind S R L	Processo di preparazione di sistemi colloidali concentrati
US10809614B2 (en)	2018-06-15	2020-10-20	Samsung Electronics Co., Ltd.	Pellicle for photomask and method of fabricating the same
US10869825B2 (en)	2015-10-29	2020-12-22	Lg Household & Health Care Ltd.	Occlusive formulations
US20210093519A1 (en) *	2018-03-29	2021-04-01	Ultrasun Ag	Process for the preparation of a base formulation for a dermatological sunscreen composition and for the preparation of a dermatological sunscreen composition
US11576872B2 (en)	2017-05-08	2023-02-14	Flagship Pioneering Innovations V, Inc.	Compositions for facilitating membrane fusion and uses thereof
US11779532B2 (en)	2020-06-12	2023-10-10	Mary Kay Inc.	Topical compositions and methods

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL152486A0 (en)	2002-10-25	2003-05-29	Meir Eini	Alcohol-free cosmetic and pharmaceutical foam carrier
US8636982B2 (en)	2007-08-07	2014-01-28	Foamix Ltd.	Wax foamable vehicle and pharmaceutical compositions thereof
JP5798745B2 (ja)	2007-10-02	2015-10-21	クースゲーエムベーハー	局所適用化粧品組成物又は医薬品組成物
JP2010043027A (ja) *	2008-08-13	2010-02-25	Kracie Home Products Ltd	水中油型乳化化粧料
JP5503175B2 (ja) *	2009-03-30	2014-05-28	株式会社コーセー	クラッキングエアゾール組成物
WO2011013009A2 (en)	2009-07-29	2011-02-03	Foamix Ltd.	Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US10029013B2 (en)	2009-10-02	2018-07-24	Foamix Pharmaceuticals Ltd.	Surfactant-free, water-free formable composition and breakable foams and their uses
ES2421932T3 (es)	2010-03-04	2013-09-06	Neubourg Skin Care Gmbh & Co Kg	Formulaciones de espuma para el tratamiento de enfermedades cutáneas en los animales
DE202011100483U1 (de)	2011-05-10	2011-07-13	Neubourg Skin Care Gmbh & Co. Kg	Applikationssystem für Pflegeprodukte mit Schwammapplikator
JP5802057B2 (ja) *	2011-05-31	2015-10-28	日本ゼトック株式会社	水中油型乳化化粧料
KR101867847B1 (ko) *	2011-11-18	2018-06-19	코웨이 주식회사	재결정 입자를 갖는 수중유 유화 조성물 및 이를 포함하는 화장료 조성물
JP6315743B2 (ja) *	2012-08-30	2018-04-25	横浜油脂工業株式会社	ラメラ構造を有する脂質成分のシリカマイクロカプセル及びその製造方法
JP2016523903A (ja) *	2013-07-01	2016-08-12	ネオファームシーオー．，エルティーディー．ＮｅｏｐｈａｒｍＣｏ．，Ｌｔｄ．	多層状乳化構造の経皮薬物送達システム
JP6775925B2 (ja) *	2014-08-19	2020-10-28	御木本製薬株式会社	Ｏ／ｗ型エマルション
US9895311B2 (en) *	2014-09-25	2018-02-20	Pharmiva Ab	Foam-forming compositions and methods for delivering an active to a body cavity
EP3442490A4 (de) *	2016-04-12	2019-12-11	Bio-Up Mimetic Technologies, Inc.	Nachgeölte und hypergeölte lecithinträgermittelvehikel
MX2020012139A (es)	2016-09-08	2021-01-29	Vyne Pharmaceuticals Inc	Composiciones y metodos para tratar rosacea y acne.
CH713023A2 (de) *	2016-10-11	2018-04-13	Kuhs Bernd	Verfahren zur Herstellung von dermatologischen und kosmetischen Präparaten mit ausgeprägten lamellaren Strukturen unter Verwendung von Phosphatidylcholin und biologischen Zellmaterialien, welche durch die Einwirkung von Ultraschallwellen aufgeschlossen werden und gleichzeitig zwischen den lamellaren Strukturen eingelagert werden.
DE102016222160A1 (de) *	2016-11-11	2018-05-17	Beiersdorf Ag	Gesichtsreinigungsprodukt mit besonderer Schaumqualität und Sensorik
DE102016224030A1 (de) *	2016-12-02	2018-06-07	Beiersdorf Ag	Kosmetischer Schaum aus einer O/W-Emulsion mit einem Veresterungsprodukte aus Glycerin mit drei identischen Fettsäuren
CN110494190A (zh)	2016-12-29	2019-11-22	玫琳凯有限公司	包含牛油树脂的化妆品组合物
CN108434090A (zh) *	2017-02-14	2018-08-24	高药品股份有限公司	以生理脂肪为基剂的类固醇药膏
JP7012211B2 (ja) *	2017-10-03	2022-01-28	東洋エアゾール工業株式会社	エアゾール製品
CH714305B1 (de) *	2017-11-06	2022-07-15	Cosmetolab Ag	Verfahren zur Herstellung von topischen Formulierungen und hergestellte Formulierungen.
EP3790528A4 (de)	2018-05-10	2022-03-02	Protair-X Health Solutions Inc.	Schaum-desinfektionsmittelzusammensetzung
CN110538091A (zh)	2018-05-29	2019-12-06	玫琳凯有限公司	局部用组合物和方法
DE102020201799A1 (de)	2020-02-13	2021-08-19	Beiersdorf Aktiengesellschaft	Polyacrylat-freie kosmetische Zubereitung
EP4195926B1 (de) *	2020-08-14	2024-08-21	nsc pharma GmbH & Co. KG	Alkoholhaltiger desinfektionsschaum
DE102021002698A1 (de)	2021-05-25	2022-12-01	Prof4Skin Gmbh	Zusammensetzungen enthaltend membranbildende Substanzen zur Herstellung eines Pumpschaumes
CN116082087B (zh) *	2022-12-28	2024-07-30	青岛阿道姆农业科技有限公司	一种用于防治植物黄化的褐藻多酚铁复合物及其制备方法
KR20250009905A (ko)	2023-07-11	2025-01-20	이동현	프리스트레스 보강재를 이용한 자립식 흙막이 가시설

Citations (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3793464A (en) *	1971-04-26	1974-02-19	Ici America Inc	Process for preparing aqueous emulsion of proteinaceous food products
US4200551A (en) *	1978-11-27	1980-04-29	A. E. Staley Manufacturing Company	Cold-water-dispersible lecithin concentrates
JPS5646810B1 (de) *	1971-05-10	1981-11-05
US4411926A (en) *	1982-02-04	1983-10-25	General Foods Corporation	Stabilizer for frozen foamed emulsions and method therefore
US4622074A (en) *	1984-03-01	1986-11-11	Miyoshi Kasei Co., Ltd.	Pigments and extender pigments which are surface-treated with hydrogenated lecithin, and cosmetics containing the same
US5120528A (en) *	1991-06-12	1992-06-09	Block Drug Company, Inc.	Taste preserving, mild oral hygiene compositions
US5709849A (en) *	1989-09-20	1998-01-20	Shiseido Company Ltd	Suppressing stickiness to skin of cosmetic composition
US6312703B1 (en) *	1998-02-06	2001-11-06	Lecigel, Llc	Compressed lecithin preparations
US6342238B1 (en) *	1999-09-06	2002-01-29	L'oreal	Organogel comprising an oxidation-sensitive hydrophilic compound, and uses thereof, in particular cosmetic uses
US6416771B1 (en) *	1995-03-23	2002-07-09	The Nisshin Oil Mills Ltd.	Moisturizing composition, base containing the same, and cosmetic or external preparation containing the moisturizing composition
US20030083210A1 (en) *	2001-08-24	2003-05-01	Unilever Home And Personal Care Usa, Division Of Conopco, Inc.	Lamellar post foaming cleansing composition and dispensing system
US20040213819A1 (en) *	2000-02-25	2004-10-28	Martin Albrecht	Cosmetic composition
US20050013833A1 (en) *	2001-07-27	2005-01-20	Jean-Thierry Simonnet	Composition based on lipid lamellar vesicles incorporating at least a dhea compound
US20050112188A1 (en) *	2003-11-17	2005-05-26	Eliaz Rom E.	Composition and dosage form comprising an amphiphilic molecule as a suspension vehicle
US20050244342A1 (en) *	2002-10-25	2005-11-03	Foamix Ltd.	Moisturizing foam containing lanolin
US20060029657A1 (en) *	2004-03-26	2006-02-09	Stiefel Laboratories, Inc.	Topical skin protectant compositions
US7052716B1 (en) *	1998-08-01	2006-05-30	Beiersdorf Ag	Cosmetic and dermatological preparations comprising an effective content of bile acids, their salts and/or their derivatives
US20060115440A1 (en) *	2004-09-07	2006-06-01	Arata Andrew B	Silver dihydrogen citrate compositions
US20080206317A1 (en) *	2004-01-23	2008-08-28	Camurus Ab	Ternary Non-Lamellar Lipid Compositions
US20080274172A1 (en) *	2005-11-30	2008-11-06	Italfarmaco, S.A.	Liposome Preparation Method
US20120164214A1 (en) *	2009-08-27	2012-06-28	Technion Research & Development Foundation Ltd.	Liposomal compositions and uses of same
US20140065260A1 (en) *	2008-04-03	2014-03-06	Ajinomoto Co., Inc.	Feed additive composition for ruminants containing acidic or neutral amino acid, and method for production thereof
US20140178320A1 (en) *	2012-12-20	2014-06-26	L'oreal	Water-in-oil emulsion comprising pigments in the water phase

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5112591B1 (de) *	1970-12-28	1976-04-20
FR2709666B1 (fr) *	1993-09-07	1995-10-13	Oreal	Composition cosmétique ou dermatologique constituée d'une émulsion huile dans eau à base de globules huileux pourvus d'un enrobage cristal liquide lamellaire.
FR2725369B1 (fr) *	1994-10-07	1997-01-03	Oreal	Composition cosmetique ou dermatologique constituee d'une emulsion huile dans eau a base de globules huileux pourvus d'un enrobage cristal liquide lamellaire
US6440729B1 (en) *	1995-06-30	2002-08-27	University Of Kansas Medical Center	Treating angiogenesis-mediated diseases with the α2 monomer of type IV collagen
US6015574A (en) *	1997-06-09	2000-01-18	L'oreal	Lipophilic carrier systems
TW592713B (en) *	1998-05-11	2004-06-21	Ciba Sc Holding Ag	Use of nanodispersions in cosmetic end formulations
DE19859427A1 (de) *	1998-12-22	2000-06-29	Beiersdorf Ag	Kosmetische oder pharmazeutische lecithinhaltige Gele oder niedrigviskose, lecithinhaltige O/W-Mikroemulsionen
FR2802805B1 (fr) *	1999-12-22	2002-08-16	Cognis Deutschland Gmbh	Melanges cosmetiques a base d'agents emulsionnants et de composes huileux, aptes a la formation de phases lamellaires liquides
FR2825629A1 (fr) *	2001-06-11	2002-12-13	Oreal	Composition de nettoyage de la peau
JP4549625B2 (ja) *	2002-01-05	2010-09-22	株式會社アモーレパシフィック	人参サポニン代謝産物を有効成分とする微細乳化粒子及びその製造方法、並びにこれを含有する皮膚老化防止用の化粧料組成物
DE10216508A1 (de) *	2002-04-11	2003-10-23	Beiersdorf Ag	Kosmetische und dermatologische Formulierungen mit einem Gehalt an Hydroxybenzophenonen und einem oder mehreren vorgelatinisierten, quervernetzten Stärkederivaten
JP2004331610A (ja) *	2003-05-09	2004-11-25	Taiyo Kagaku Co Ltd	油状泡沫性ｕｖケア化粧料組成物
US20050265936A1 (en) *	2004-05-25	2005-12-01	Knopf Michael A	Cleansing foaming sunscreen lotion
JP2007008853A (ja) *	2005-06-30	2007-01-18	Pola Chem Ind Inc	エアゾル化粧料
US7920823B2 (en) *	2006-12-08	2011-04-05	Microsoft Corporation	System capability discovery for software defined radio
CL2008000037A1 (es) *	2007-01-16	2008-10-10	Bayer Consumer Care Ag	Solucion coloidal que comprende al menos un ingrediente activo, al menos una molecula formadora de membrana y al menos un componente espumante; procedimiento para fabricar la solucion coloidal; y su uso para tratar trastornos dermatologicos.

2007
- 2007-06-19 ES ES07110571T patent/ES2382890T3/es active Active
- 2007-06-19 EP EP07110571A patent/EP2020221B1/de active Active
- 2007-06-19 RS RS20120210A patent/RS52337B/sr unknown
- 2007-06-19 PL PL07110571T patent/PL2020221T3/pl unknown
- 2007-06-19 DK DK07110571.2T patent/DK2020221T3/da active
- 2007-06-19 AT AT07110571T patent/ATE547088T1/de active
- 2007-06-19 PT PT07110571T patent/PT2020221E/pt unknown
2008
- 2008-06-19 KR KR1020237007123A patent/KR20230037060A/ko not_active Abandoned
- 2008-06-19 KR KR1020177002494A patent/KR20170016013A/ko not_active Ceased
- 2008-06-19 CA CA2691393A patent/CA2691393C/en active Active
- 2008-06-19 KR KR1020187018115A patent/KR20180074816A/ko not_active Ceased
- 2008-06-19 UA UAA201000511A patent/UA98499C2/uk unknown
- 2008-06-19 EP EP08761225A patent/EP2167015A2/de not_active Withdrawn
- 2008-06-19 EA EA201070028A patent/EA021149B1/ru not_active IP Right Cessation
- 2008-06-19 KR KR1020107001136A patent/KR20100031749A/ko not_active Ceased
- 2008-06-19 EP EP14181865.8A patent/EP2815737A1/de not_active Ceased
- 2008-06-19 AU AU2008265154A patent/AU2008265154B2/en active Active
- 2008-06-19 KR KR1020157031018A patent/KR20150126419A/ko not_active Ceased
- 2008-06-19 WO PCT/EP2008/057791 patent/WO2008155389A2/de not_active Ceased
- 2008-06-19 KR KR1020207027482A patent/KR20200116166A/ko not_active Ceased
- 2008-06-19 MX MX2009013348A patent/MX2009013348A/es active IP Right Grant
- 2008-06-19 CN CN200880020965XA patent/CN101686903B/zh active Active
- 2008-06-19 JP JP2010512690A patent/JP5971891B2/ja active Active
- 2008-06-19 US US12/664,732 patent/US20100189662A1/en not_active Abandoned
2009
- 2009-11-05 ZA ZA200907797A patent/ZA200907797B/xx unknown
- 2009-11-12 IL IL202088A patent/IL202088A0/en active IP Right Grant
2010
- 2010-08-03 HK HK15105333.8A patent/HK1206588A1/xx unknown
2012
- 2012-05-17 HR HRP20120423TT patent/HRP20120423T1/hr unknown
2014
- 2014-09-08 JP JP2014182366A patent/JP6381379B2/ja active Active
2019
- 2019-02-08 US US16/270,929 patent/US20190167539A1/en not_active Abandoned
- 2019-10-15 US US16/601,733 patent/US20200289381A1/en not_active Abandoned
2021
- 2021-04-20 US US17/235,152 patent/US20220110842A1/en not_active Abandoned
2024
- 2024-03-20 US US18/610,728 patent/US20240374485A1/en active Pending

Patent Citations (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3793464A (en) *	1971-04-26	1974-02-19	Ici America Inc	Process for preparing aqueous emulsion of proteinaceous food products
JPS5646810B1 (de) *	1971-05-10	1981-11-05
US4200551A (en) *	1978-11-27	1980-04-29	A. E. Staley Manufacturing Company	Cold-water-dispersible lecithin concentrates
US4411926A (en) *	1982-02-04	1983-10-25	General Foods Corporation	Stabilizer for frozen foamed emulsions and method therefore
US4622074A (en) *	1984-03-01	1986-11-11	Miyoshi Kasei Co., Ltd.	Pigments and extender pigments which are surface-treated with hydrogenated lecithin, and cosmetics containing the same
US5709849A (en) *	1989-09-20	1998-01-20	Shiseido Company Ltd	Suppressing stickiness to skin of cosmetic composition
US5120528A (en) *	1991-06-12	1992-06-09	Block Drug Company, Inc.	Taste preserving, mild oral hygiene compositions
US6416771B1 (en) *	1995-03-23	2002-07-09	The Nisshin Oil Mills Ltd.	Moisturizing composition, base containing the same, and cosmetic or external preparation containing the moisturizing composition
US6312703B1 (en) *	1998-02-06	2001-11-06	Lecigel, Llc	Compressed lecithin preparations
US7052716B1 (en) *	1998-08-01	2006-05-30	Beiersdorf Ag	Cosmetic and dermatological preparations comprising an effective content of bile acids, their salts and/or their derivatives
US6342238B1 (en) *	1999-09-06	2002-01-29	L'oreal	Organogel comprising an oxidation-sensitive hydrophilic compound, and uses thereof, in particular cosmetic uses
US7001604B2 (en) *	2000-02-25	2006-02-21	Kubs Kosmetik Gmbh & Co. Kg	Cosmetic composition
US20040213819A1 (en) *	2000-02-25	2004-10-28	Martin Albrecht	Cosmetic composition
US20050013833A1 (en) *	2001-07-27	2005-01-20	Jean-Thierry Simonnet	Composition based on lipid lamellar vesicles incorporating at least a dhea compound
US20030083210A1 (en) *	2001-08-24	2003-05-01	Unilever Home And Personal Care Usa, Division Of Conopco, Inc.	Lamellar post foaming cleansing composition and dispensing system
US20050244342A1 (en) *	2002-10-25	2005-11-03	Foamix Ltd.	Moisturizing foam containing lanolin
US20050112188A1 (en) *	2003-11-17	2005-05-26	Eliaz Rom E.	Composition and dosage form comprising an amphiphilic molecule as a suspension vehicle
US20080206317A1 (en) *	2004-01-23	2008-08-28	Camurus Ab	Ternary Non-Lamellar Lipid Compositions
US20060029657A1 (en) *	2004-03-26	2006-02-09	Stiefel Laboratories, Inc.	Topical skin protectant compositions
US20060115440A1 (en) *	2004-09-07	2006-06-01	Arata Andrew B	Silver dihydrogen citrate compositions
US20080274172A1 (en) *	2005-11-30	2008-11-06	Italfarmaco, S.A.	Liposome Preparation Method
US20140065260A1 (en) *	2008-04-03	2014-03-06	Ajinomoto Co., Inc.	Feed additive composition for ruminants containing acidic or neutral amino acid, and method for production thereof
US20120164214A1 (en) *	2009-08-27	2012-06-28	Technion Research & Development Foundation Ltd.	Liposomal compositions and uses of same
US20140178320A1 (en) *	2012-12-20	2014-06-26	L'oreal	Water-in-oil emulsion comprising pigments in the water phase

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20110308985A1 (en) *	2009-02-26	2011-12-22	Gina Van Bogaert	Composition of a liposomal gel containing hydrocortisone, its metabolites, precursors or mixtures thereof and the use thereof
US9693956B2 (en)	2009-07-24	2017-07-04	Mika Pharma Gmbh	Liquid compositions capable of foaming and including active agents, and methods for making or developing same
US9468590B2 (en)	2009-12-10	2016-10-18	Neubourg Skin Care Gmbh & Co. Kg	Emulsifier-free, polymer-stabilized foam formulations
US20120315315A1 (en) *	2010-03-02	2012-12-13	Neubourg Skin Care Gmbh & Co., Kg	Foam Formulations Containing at Least One Triterpenoid
US10660844B2 (en)	2011-06-23	2020-05-26	Cosmetic Warriors Limited	Solid non-edible cosmetic composition
US9884005B2 (en)	2011-06-23	2018-02-06	Cosmetic Warriors Limited	Aerated solid cosmetic composition
US10111826B2 (en)	2012-12-11	2018-10-30	Cosmetic Warriors Limited	Solid cosmetic composition having dispersed therein gas bubbles, and a process for making a solid cosmetic composition
US20150359723A1 (en) *	2013-02-19	2015-12-17	Neopharm Co., Ltd.	Composition externally used for subacid skin and cosmetic material including same
WO2016044374A1 (en) *	2014-09-18	2016-03-24	Glaxosmithkline Consumer Healthcare Holdings (Us) Llc	Novel formulations
US11324686B2 (en)	2015-10-29	2022-05-10	Lg Household & Health Care Ltd.	Occlusive formulations
US10869825B2 (en)	2015-10-29	2020-12-22	Lg Household & Health Care Ltd.	Occlusive formulations
EP3338759A1 (de) *	2016-11-22	2018-06-27	CMS Lab Inc.	Vesikel, die saccharidisomerate, hydrolysierte lupineproteine und interkorneozytäre lipid-mimetika als wirkstoff enthalten, und zusammensetzung damit zur äusseren anwendung auf der haut
US11576872B2 (en)	2017-05-08	2023-02-14	Flagship Pioneering Innovations V, Inc.	Compositions for facilitating membrane fusion and uses thereof
WO2019194780A3 (en) *	2017-12-27	2020-01-02	Montero Gida Sanayi Ve Ticaret Anonim Sirketi	Sensitive care and cleansing compositions
US20210093519A1 (en) *	2018-03-29	2021-04-01	Ultrasun Ag	Process for the preparation of a base formulation for a dermatological sunscreen composition and for the preparation of a dermatological sunscreen composition
US12453679B2 (en) *	2018-03-29	2025-10-28	Ultrasun Ag	Method for the preparation of a base formulation for a dermatological sunscreen composition and for the preparation of a dermatological sunscreen composition
US11262648B2 (en)	2018-06-15	2022-03-01	Samsung Electronics Co., Ltd.	Pellicle for photomask and method of fabricating the same
US10809614B2 (en)	2018-06-15	2020-10-20	Samsung Electronics Co., Ltd.	Pellicle for photomask and method of fabricating the same
IT201900004877A1 (it) *	2019-04-01	2020-10-01	Res Pharma Ind S R L	Processo di preparazione di sistemi colloidali concentrati
US11779532B2 (en)	2020-06-12	2023-10-10	Mary Kay Inc.	Topical compositions and methods

Also Published As

Publication number	Publication date
AU2008265154B2 (en)	2011-12-15
CA2691393A1 (en)	2008-12-24
EP2167015A2 (de)	2010-03-31
EP2020221B1 (de)	2012-02-29
JP2015007115A (ja)	2015-01-15
IL202088A0 (en)	2010-06-16
RS52337B (sr)	2012-12-31
KR20230037060A (ko)	2023-03-15
CN101686903B (zh)	2013-09-04
US20220110842A1 (en)	2022-04-14
KR20200116166A (ko)	2020-10-08
HK1129562A1 (en)	2009-12-04
JP2010530400A (ja)	2010-09-09
HRP20120423T1 (hr)	2012-07-31
US20200289381A1 (en)	2020-09-17
EP2020221A1 (de)	2009-02-04
CA2691393C (en)	2017-11-21
EA201070028A1 (ru)	2010-04-30
WO2008155389A3 (de)	2009-05-22
KR20150126419A (ko)	2015-11-11
ZA200907797B (en)	2010-06-30
MX2009013348A (es)	2010-01-18
UA98499C2 (uk)	2012-05-25
US20240374485A1 (en)	2024-11-14
US20190167539A1 (en)	2019-06-06
ES2382890T3 (es)	2012-06-14
HK1206588A1 (en)	2016-01-15
PL2020221T3 (pl)	2012-07-31
KR20100031749A (ko)	2010-03-24
KR20170016013A (ko)	2017-02-10
JP5971891B2 (ja)	2016-08-17
WO2008155389A2 (de)	2008-12-24
DK2020221T3 (da)	2012-06-25
KR20180074816A (ko)	2018-07-03
AU2008265154A1 (en)	2008-12-24
JP6381379B2 (ja)	2018-08-29
EP2815737A1 (de)	2014-12-24
PT2020221E (pt)	2012-05-30
CN101686903A (zh)	2010-03-31
EA021149B1 (ru)	2015-04-30
ATE547088T1 (de)	2012-03-15

Publication	Publication Date	Title
US20240374485A1 (en)	2024-11-14	DMS (derma membrane structure) in Foam Creams
AU2008250298B2 (en)	2011-12-22	Surfactant-free foam formulations
EP2509565B1 (de)	2018-05-30	Emulgatorfreie, polymerstabilisierte schaumformulierungen
HK1129562B (en)	2012-07-20	Dms (derma membrane structure) in foaming creams

Legal Events

Date	Code	Title	Description
2010-01-13	AS	Assignment	Owner name: NEUBOURG SKIN CARE GMBH & CO KG, GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NEUBOURG, THOMAS;REEL/FRAME:023775/0609 Effective date: 20091207
2019-03-08	STCB	Information on status: application discontinuation	Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION

Date

Code

Title

Description

2010-01-13

Assignment

Owner name: NEUBOURG SKIN CARE GMBH & CO KG, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NEUBOURG, THOMAS;REEL/FRAME:023775/0609

Effective date: 20091207

2019-03-08

STCB

Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION